# Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas

> **NCT03161054** · PHASE2 · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 21 (actual)

## Conditions studied

- Aggressive Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Vinorelbine
- **DRUG:** Etoposide
- **DRUG:** Cyclophosphamide
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT03161054
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-12
- **Primary completion:** 2020-04-22
- **Final completion:** 2021-06-21
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03161054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03161054, "Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03161054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*